Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.

Abstract:

BACKGROUND:Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate. STUDY DESIGN:Forty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7. RESULTS:Sixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups. CONCLUSION:In contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC.

journal_name

Contraception

journal_title

Contraception

authors

Rible RD,Taylor D,Wilson ML,Stanczyk FZ,Mishell DR Jr

doi

10.1016/j.contraception.2008.10.005

subject

Has Abstract

pub_date

2009-03-01 00:00:00

pages

182-8

issue

3

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(08)00486-1

journal_volume

79

pub_type

杂志文章,随机对照试验
  • Factors associated with contraceptive nonuse among US women ages 35-44 years at risk of unwanted pregnancy.

    abstract:BACKGROUND:Women ages 35 years and older have the greatest proportion of contraceptive nonuse and unintended pregnancies ending in abortion. STUDY DESIGN:We conducted a population-based case-control study among women ages 35-44 years at risk of unwanted pregnancy using the National Survey of Family Growth (NSFG) data ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2009.12.013

    authors: Upson K,Reed SD,Prager SW,Schiff MA

    更新日期:2010-05-01 00:00:00

  • Metabolic and endocrine studies in women using norethindrone acetate implant.

    abstract::Subcutaneously administered implant-D containing 40 mg of Norethindrone acetate in a single silastic implant was offered to 79 subjects who desired spacing of their family. The effect of constant release of steroid from this device on metabolic and endocrine functions was studied. Each subject in the pretreatment stat...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(79)80026-8

    authors: Shahani SM,Kulkarni PP,Bhate PA,Patel KL

    更新日期:1979-02-01 00:00:00

  • Postovulatory contraception in women with large doses of norethindrone.

    abstract::To test the contraceptive efficacy of norethindrone (NET), the effect of NET on peripheral plasma levels of progesterone and estradiol after ovulation was investigated, since low levels of ovarian steroids might affect the postovulatory endometrium and thereby impair normal blastocyst implantation. Two studies were ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(72)90011-x

    authors: Nygren KG,Johansson ED,Wide L

    更新日期:1972-06-01 00:00:00

  • Effect of polyphloretin phosphate on the contraceptive action of a polyethylene intrauterine device in rats.

    abstract::A polyethylene intrauterine device (IUD) inserted in one horn of the rat uterus on Day 2 of pregnancy prevented implantation in 9 out of 12 rats in the horn with the device. When polyphloretin phosphate (PPP), a substance known to inhibit alkaline phosphatase, was administered to such rats from Day 1 till Day 5 of pre...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90016-1

    authors: Chaudhury MR

    更新日期:1983-08-01 00:00:00

  • Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).

    abstract::Abortion was attempted in 39 women in early pregnancy (less than 56 days amenorrhea) with the progesterone antagonist RU486 alone (150 mg per day for 4 days) or in combination with a PG analogue, 16,16-dimethyl-trans-delta 2-PGE1 (Gemeprost) in the form of a 1 mg vaginal pessary. Complete abortion was also attempted i...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(86)90055-7

    authors: Cameron IT,Michie AF,Baird DT

    更新日期:1986-11-01 00:00:00

  • Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial.

    abstract:BACKGROUND:Barriers to intrauterine device (IUD) use in nulliparous women include fear of pain with insertion and provider perception of difficulty with insertion. The goal of this study was to evaluate whether misoprostol prior to IUD insertion in nulliparous women eased insertion and decreased pain. STUDY DESIGN:Thi...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2013.07.011

    authors: Lathrop E,Haddad L,McWhorter CP,Goedken P

    更新日期:2013-12-01 00:00:00

  • Estimating systemic exposure to levonorgestrel from an oral contraceptive.

    abstract:OBJECTIVE:The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies fo...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2016.12.007

    authors: Basaraba CN,Westhoff CL,Pike MC,Nandakumar R,Cremers S

    更新日期:2017-04-01 00:00:00

  • STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.

    abstract::STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9(10)-diene-3-one) is a potent progestin. This compound was 10 times as potent as the standard levonorgestrel as judged by the classic Clauberg-McPhail Assay. The antiprogestational response is significant when STS 557 treatment starts 2 days before progesterone ad...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90140-7

    authors: Oettel M,Kurischko A

    更新日期:1980-01-01 00:00:00

  • Monthly combined injectable contraceptives and neoplasia.

    abstract::Monthly injectable contraceptives, containing a combination of a long-acting progestogen and an estrogen, have been used in Latin America and China for many years. While knowledge about the effects of other hormonal contraceptives on cancer risk is relevant, close analogies with monthly injectables cannot be made. The...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/0010-7824(94)90002-7

    authors: Skegg DC

    更新日期:1994-05-01 00:00:00

  • A comparative study of Neo Sampoon, Ortho Vaginal Tablets and Emko Vaginal Tablets in Accra, Ghana.

    abstract::Neo Sampoon is an effervescent contraceptive vaginal tablet manufactured in Japan that contains 60 mg of the spermicide menfegol. Ortho Vaginal Tablets (OVT) and Emko Vaginal Tablets (EVT), both containing 100 mg of the spermicide nonoxynol-9, were manufactured in the USA. The three products were compared in a randomi...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(85)90015-0

    authors: Lamptey P,Klufio C,Smith SC,Feldblum PJ

    更新日期:1985-11-01 00:00:00

  • Exploring emergency contraception prescribing by pharmacists in California.

    abstract:OBJECTIVE:To understand knowledge, current practices, barriers and facilitators for pharmacists prescribing emergency contraception (EC). STUDY DESIGN:We conducted a cross-sectional survey among California community pharmacists. We distributed the online survey, consisting of 34 close-ended questions, to members of th...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.08.012

    authors: Mody SK,Rafie S,Hildebrand M,Oakley LP

    更新日期:2019-12-01 00:00:00

  • Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE).

    abstract:OBJECTIVES:To compare the pharmacokinetic parameters and safety of the progestagen, Org 30659, (17alpha)-17-hydroxy-11-methylene-19-norpregna-4,15-dien-20-yn-3-one), and ethinyl estradiol (EE) in Caucasian and Japanese women after single and multiple doses. METHODS:This was an open-label parallel design of a single do...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(03)00140-9

    authors: de Visser SJ,Uchida N,van Vliet-Daskalopoulou E,Fukazawa I,van Doorn MB,van den Heuvel MW,Machielsen CS,Uchida E,Cohen AF

    更新日期:2003-09-01 00:00:00

  • Mobile phone ownership, text messages, and contraceptive use: Is there a digital revolution in family planning?

    abstract:OBJECTIVES:This study aims to clarify the associations between mobile phone ownership use on family planning outcomes. Secondary analysis of DHS data finds that in certain contexts, mobile phone ownership may be related to increased FP uptake. STUDY DESIGN:Using recent data for women 15-49 from the Demographic and Hea...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.10.004

    authors: Jadhav A,Weis J

    更新日期:2020-02-01 00:00:00

  • Medicaid and fulfillment of desired postpartum sterilization.

    abstract:OBJECTIVE:We sought to assess fulfillment of sterilization requests while accounting for the complex interplay between insurance, clinical and social factors in a contemporary context that included both inpatient and outpatient postpartum sterilization procedures. STUDY DESIGN:This is a retrospective single-center coh...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.02.012

    authors: Arora KS,Wilkinson B,Verbus E,Montague M,Morris J,Ascha M,Mercer BM

    更新日期:2018-06-01 00:00:00

  • Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.

    abstract::A prospective randomized trial was conducted in 140 women to compare the efficacy of vaginal gemeprost with vaginal misoprostol for termination of second trimester pregnancy. Women requesting termination of second trimester pregnancy were randomized into two groups. Group A women were given 1 mg vaginal gemeprost ever...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(98)00099-7

    authors: Wong KS,Ngai CS,Wong AY,Tang LC,Ho PC

    更新日期:1998-10-01 00:00:00

  • The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods.

    abstract::A placebo-controlled, double-blind study was carried out to assess the direct hormonal effects of combined and progestogen-only oral contraceptives on well-being and sexuality of women in two contrasting cultures. One-hundred-fifty women, who had been sterilised or whose partners had been vasectomised, were recruited ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/0010-7824(95)00226-x

    authors: Graham CA,Ramos R,Bancroft J,Maglaya C,Farley TM

    更新日期:1995-12-01 00:00:00

  • The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changes.

    abstract::A longitudinal study of coagulation parameters was carried out on 100 Singaporean acceptors using the levonorgestrel subdermal implants NORPLANT for contraceptive purposes. At the end of 1 year of use, results from this on-going study indicate that these subjects may have an increased predisposition to thrombosis as e...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(88)90103-5

    authors: Viegas OA,Singh K,Koh S,Singh P,Ratnam SS

    更新日期:1988-09-01 00:00:00

  • Women's experiences with doula support during first-trimester surgical abortion: a qualitative study.

    abstract:OBJECTIVE:To explore how doula support influences women's experiences with first-trimester surgical abortion. STUDY DESIGN:We conducted semistructured interviews with women given the option to receive doula support during first-trimester surgical abortion in a clinic that uses local anesthesia and does not routinely a...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2015.10.006

    authors: Chor J,Lyman P,Tusken M,Patel A,Gilliam M

    更新日期:2016-03-01 00:00:00

  • Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.

    abstract::There is concern that the breast-fed infant whose mother is receiving intra-muscular progestogens for contraception will be exposed to significant quantities of the steroid. Norethisterone levels in maternal serum and milk were studied throughout an injection interval after intramuscular administration of 200mg noreth...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90073-2

    authors: Fotherby K,Towobola O,Muggeridge J,Elder MG

    更新日期:1983-11-01 00:00:00

  • A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.

    abstract:OBJECTIVES:This open-label non-inferiority study assessed efficacy of a common outpatient medical abortion regimen among people with pregnancies 64-70 days and 71-77 days of gestation. STUDY DESIGN:We defined non-inferiority by a 6% margin of method success. People with intrauterine pregnancies 64-77 days' gestational...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.01.009

    authors: Dzuba IG,Chong E,Hannum C,Lichtenberg ES,Lugo Hernández EM,Ngoc NTN,Patel A,Rzayeva G,Sanhueza Smith P,Tsertsvadze G,Winikoff B

    更新日期:2020-05-01 00:00:00

  • Medications to ease intrauterine device insertion: a systematic review.

    abstract:BACKGROUND:Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women. OBJECTIVE:This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adj...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.06.014

    authors: Zapata LB,Jatlaoui TC,Marchbanks PA,Curtis KM

    更新日期:2016-12-01 00:00:00

  • The Management of a patient with a fragmented intrauterine device embedded within the cervical canal.

    abstract::A 28-year-old woman presented with a malpositioned intrauterine device (IUD) that was fragmented and significantly entrenched within the cervical canal and myometrium. IUD malposition with concomitant device fragmentation and embedded segments, albeit rare, should be a consideration given the device's prevalence. ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.08.010

    authors: Korber PE,Goldstein BH

    更新日期:2019-01-01 00:00:00

  • Progestogen-only contraceptive use among breastfeeding women: a systematic review.

    abstract:BACKGROUND:The use of progestogen-only contraceptives by breastfeeding women raises theoretical concerns regarding possible adverse effects on breastfeeding success, and infant health or growth. This review was conducted to determine from the literature whether use of progestogen-only contraceptives by breastfeeding wo...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2010.02.002

    authors: Kapp N,Curtis K,Nanda K

    更新日期:2010-07-01 00:00:00

  • Over-the-internet availability of hormonal contraceptives regardless of risk factors.

    abstract:OBJECTIVE:The purpose of this study is to measure the accessibility to purchase oral and transdermal contraceptives over the Internet for low- and high-risk individuals. METHODS:The Internet was used to search for and order both oral and transdermal contraceptives. Using the "Google" search engine to locate online pha...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.10.001

    authors: Memmel LM,Miller L,Gardner J

    更新日期:2006-04-01 00:00:00

  • Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study.

    abstract:BACKGROUND:This study investigated the effects of adding levomefolate calcium 0.451 mg (the calcium salt of L-5-methyltetrahydrofolate; Metafolin®) to an oral contraceptive containing ethinylestradiol (EE) 20 mcg/drospirenone (drsp) 3 mg on folate levels in healthy women seeking contraception. STUDY DESIGN:In this ran...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.contraception.2011.05.013

    authors: Bart S Sr,Marr J,Diefenbach K,Trummer D,Sampson-Landers C

    更新日期:2012-01-01 00:00:00

  • Sociocultural and religious influences on the normative contraceptive practices of Latino women in the United States.

    abstract::Presumably, Latino women engage in little family planning because of religious or cultural objections to contraception. The purpose of this study was to examine how acculturation, religion and various demographic factors were related to the family-planning behaviors of Latino women in the United States. Data were coll...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2003.10.011

    authors: Romo LF,Berenson AB,Segars A

    更新日期:2004-03-01 00:00:00

  • Vaginal misoprostol for late first trimester abortion.

    abstract::A group of 120 women with gestations from 64 to 84 days received 800 micrograms of vaginal misoprostol every 24 h for a maximum of three doses without performing postexpulsion systematic preventive curettage. Outcome measures included successful abortion (complete abortion without requiring a surgical procedure), side...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(98)00037-7

    authors: Carbonell Esteve JL,Varela L,Velazco A,Cabezas E,Tanda R,Sánchez C

    更新日期:1998-05-01 00:00:00

  • Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.

    abstract:OBJECTIVES:To assess shorter mifepristone-misoprostol intervals compared to current guidelines for second trimester medical abortion on total abortion time (mifepristone to fetal expulsion) and induction time (first misoprostol to fetal expulsion). METHODS:This retrospective cohort study included women who elected for...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.06.009

    authors: Henkel A,Lerma K,Blumenthal PD,Shaw KA

    更新日期:2020-11-01 00:00:00

  • Rebound of medication abortion in Texas following updated mifepristone label.

    abstract:BACKGROUND:In 2013, Texas House Bill 2 (HB 2) placed restrictions on the use of medication abortion, which later were nullified with the 2016 FDA-approved mifepristone label. METHODS:Using data collected directly from Texas abortion facilities, we evaluated changes in the provision and use of medication abortion durin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.01.001

    authors: Baum SE,White K,Hopkins K,Potter JE,Grossman D

    更新日期:2019-05-01 00:00:00

  • Intraoperative placement of the Copper T-380 intrauterine devices in women undergoing elective cesarean delivery: a pilot study.

    abstract:BACKGROUND:The purpose of this pilot project was to test the feasibility of a technique designed to place a copper intrauterine device (IUD) through the hysterotomy incision of an elective cesarean delivery to minimize possible contamination and to guarantee that tailstrings were visible in the vagina for easy removal ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2009.01.014

    authors: Nelson AL,Chen S,Eden R

    更新日期:2009-07-01 00:00:00